CD8A and cancer: Indeed, dual blockade of PD-1 and LAG-3 results in robust and synergistic reinvigoration of Tex cells in cancer59 and chronic infection60, while NKG2A blockade has been shown to potentiate CD8+ T cell immunity induced by cancer vaccines61.